FIELD: chemistry.
SUBSTANCE: invention refers to compounds of formula (I) 
as well as to synthesis procedure and application for treatment of various disorders, including inflammatory and autoimmune disorders, and disorders caused by malignant growths or by increased angiogenesis where R1-R11, t, X, Y, Z and n have values specified in the description.
EFFECT: production of macrocyclic compounds used for treatment of various disorders, including inflammatory and autoimmune disorders, and disorders caused by malignant growths or by increased angiogenesis.
41 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HIV-INHIBITING 5-(HYDROXYMETHYLENE- AND AMINOMETHYLENE)SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2452737C2 |
| HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2764243C2 |
| INTERMEDIATE PRODUCTS IN SYNTHESIS OF ANALOGUES OF ZEARALENONE MACROLIDES | 2008 |
|
RU2497803C2 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| COMBINATION OF INHIBITORS OF FBP-ASE AND SENSITIZING AGENTS OF INSULIN FOR DIABETES MELLITUS TREATMENT | 1999 |
|
RU2227749C2 |
| N-PYRAZINYLPHENYLSULFONAMIDES AND THEIR USING IN TREATMENT OF CHEMOKINE-MEDIATED DISEASES | 2003 |
|
RU2312105C9 |
| DIPHENYLAZETIDINONE DERIVATIVES, METHODS FOR OBTAINING SAME, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS OF SAID DERIVATIVES AND APPLICATION THEREOF IN CHOLESTEROL ABSORPTION INHIBITION | 2003 |
|
RU2333199C2 |
| USE OF FORMYL PEPTIDE RECEPTOR 2 AGONISTS FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2768730C2 |
| 5-PHENYLTIAZOL DERIVATIVES AND THEIR APPLICATION IN CAPACITY OF P13 KINASE INHIBITORS | 2003 |
|
RU2378263C2 |
| MDM2 AND P53 INTERACTION INHIBITORS | 2008 |
|
RU2477724C2 |
